ElaineM.(Kozlowski)HylekMDMPH

Professor of Medicine, Boston University

Dr. Hylek is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
801 Massachusetts Ave
Crosstown 6C
Boston, MA 02118
Phone+1 617-414-5951

Fax+1 617-414-9201

Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Boston Magazine Castle Connolly, 2011-2013

PubMed

Performance of Atrial Fibrillation Burden Trends for Stroke Risk Stratification.
Jonathan P Piccini, Evan J Stanelle, Cody C Johnson, Elaine M Hylek, Rahul Kanwar
Circulation. Arrhythmia and Electrophysiology. 2024-11-01
Using Atrial Fibrillation Burden Trends and Machine Learning to Predict Near-Term Risk of Cardiovascular Hospitalization.
James Peacock, Evan J Stanelle, Lawrence C Johnson, Elaine M Hylek, Rahul Kanwar
Circulation. Arrhythmia and Electrophysiology. 2024-11-01
Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registries.
Toon Wei Lim, Alan John Camm, Saverio Virdone, Daniel E Singer, Jean P Bassand
Clinical Cardiology. 2023-11-01

Journal Articles

Treatment Persistence in Atrial Fibrillation: The Next Major Hurdle
Elaine (Kozlowski) Hylek, MD, Thrombosis and Haemostasis
Original Investigation Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients with Atrial Fibrillation: An ARISTOTLE Substudy
John H Alexander, Elaine M Hylek, ScienceDirect
Choosing a Particular Oral Anticoagulant and Dose for Stroke Prevention in Individual Patients with Non-Valvular Atrial Fibrillation: Part 1
Jonathan L Halperin, Elaine M Hylek, Michael D Ezekowitz, James Aisenberg, European Heart Journal

Lectures

Unanswered Questions on NOAC in AF Where Do We Go From Here?
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Catheter-Directed Fibrinolysis Safe in Intermediate-High-Risk Pulmonary EmbolismDecember 16th, 2022
Hints of Benefit with Catheter-Directed Thrombolysis in Intermediate/High-Risk PEOctober 19th, 2022
Catheter-Directed Thrombolysis Promising for Intermediate-Risk Pulmonary EmbolismOctober 19th, 2022
Join now to see all